glp-1 semaglutide side effects Effects: A Week-by-Week Guide & When to Call Your Provider The FDA sent a warning

Serious adverse events were balanced across groups

Top Key Players Sun Pharmaceutical Industries Ltd Sanofi Pfizer.Inc Novo-Nordisk A/S Eli Lilly and Company Boehringer Ingelheim International GmbH AstraZeneca Amylyx Pharmaceuticals Recent Developments In July 2024, Amylyx Pharmaceuticals strategically acquired Avexitide, a promising GLP-1 receptor agonist, from Eiger Biopharmaceuticals

Patients with Renal Impairment Renal impairment did not impact the exposure of semaglutide in a clinically relevant manner

Physicians Assessment : A healthcare provider will assess the patients health, medical history, weight loss goals, and current medications